Robert Iannone

Dr. Robert Iannone, MD, is an Independent Director at iTeos Therapeutics, Inc., an Independent Director at Jounce Therapeutics, Inc. and a Chief Medical Officer, EVP-Research & Development at Jazz Pharmaceuticals Plc. He is on the Board of Directors at iTeos Therapeutics, Inc. and Jounce Therapeutics, Inc. Dr. Iannone was previously employed as a Chief Medical Officer, Head-Research & Development by Immunomedics, Inc., a SVP, Head-Immuno-Oncology & Global Medicines by AstraZeneca Plc, an Executive Director & Head-Oncology by Merck & Co., Inc., and an Adjunct Assistant Professor by University of Pennsylvania Medical Center. He received his undergraduate degree from The Catholic University of America, a graduate degree from the University of Pennsylvania Medical Center and a doctorate degree from Yale School of Medicine.